Christina Baik, M.D., M.P.H.
Christina Baik, M.D., M.P.H.
Associate Member
Clinical Research Division, Fred Hutch
Dr. Christina Baik treats patients who have lung cancers and head and neck cancers. She leads clinical research studies of targeted therapies and immunotherapies for patients with these cancers. Dr. Baik also studies how these malignancies resist these forms of treatment.
Clinical Focus
Treatment of patients with thoracic, head and neck malignancies
Other Appointments & Affiliations
Attending Physician, Thoracic, Head and Neck Medical Oncology
Seattle Cancer Care Alliance
Associate Professor, Medical Oncology
University of Washington
Research Interests
Targeted therapy in oncogene driven lung cancer and understanding of resistance mechanisms to targeted therapies
Immunotherapy in lung cancer
Understanding the mechanisms of primary and secondary resistance to immunotherapy in lung cancer
Active Clinical Trials
Study of LOXO-101 in Subjects With NTRK Fusion Positive Solid Tumors (NAVIGATE)
Study Number: 20161101
Phase: I/II
Phase 2 Study of Poziotinib in Patients With NSCLC With EGFR or HER2 Exon 20 Insertion Mutation
Study Number: 20172584
Phase: II
Phase 1 Study of the Highly-selective RET Inhibitor BLU-667 in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors
Study Number: 20172740
Phase: I
DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing or -Mutated Non-Small Cell Lung Cancer
Study Number: 20182077
Phase: II
Study of Telisotuzumab Vedotin (ABBV-399) in Subjects With Previously Treated c-Met+ Non-Small Cell Lung Cancer
Study Number: RG1003659
Phase: II
For the Media
The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.
Email media@fredhutch.org or call 206.667.2210.